Dengue and Other Viral Hemorrhagic Fevers in India

被引：0
作者：
Shally Awasthi
U. C. Chaturvedi
机构：
[1] CSM Medical University,Department of Pediatrics
来源：
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences | 2012年 / 82卷
关键词：
Hemorrhagic fevers; Dengue; Kyasanur forest disease; Virion; Hantaviruses;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The important viral hemorrhagic fevers (VHF) in India spread by an arthropod vectors are Dengue fever/Dengue haemorrhagic fever and Kyasanur forest disease. Another VHF is caused by Hanta virus infection and for this there is no known vector. The diagnosis of VHF is based on typical clinical presentation and thereafter confirmed by detection of either virus or viral RNA or by demonstration of a rise of antibody titres against it. Treatment is by and large symptomatic as there are no specific drugs available against the viruses. Dengue fever has acquired epidemic magnitude in certain parts of India and has about 10% mortality. Research is going on for the development of effective vaccines against Dengue fever. The principles of primary prevention of vector borne diseases is through vector control measures, elimination of breeding sites in and around human dwellings and personal protection against vector bite.
引用
收藏
页码：69 / 80
页数：11
相关论文
共 137 条
  • [11] Halstead SB(2007)Dengue virus-specific suppressor T cells: current perspectives FEMS Immunol Med Microbiol 50 285-299
  • [12] Halstead SB(2010)Dengue in infants: an overview FEMS Immunol Med Microbiol 59 119-130
  • [13] Nimmannitya S(2009)T lymphocyte responses to heterologous secondary dengue virus infections Ann N Y Acad Sci 1171 E36-E41
  • [14] Cohen SN(2006)Dengue and dengue haemorrhagic fever: implications of host genetics FEMS Immunol Med Microbiol 47 155-166
  • [15] Sangkawibha N(2005)Dengue vaccines: problems and prospects Indian J Med Res 121 639-652
  • [16] Guzman MG(2007)Chikungunya, an epidemic arbovirosis Lancet Infect Dis 7 319-327
  • [17] Halstead SB(2000)Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218 Am J Trop Med Hyg 62 681-685
  • [18] Halstead SB(1989)Clinical, clinicopathologic, and hematologic features of Kyasanur forest disease Rev Infect Dis 11 S854-S859
  • [19] Heinz FX(2006)Kyasanur forest disease: an epidemiological view in India Rev Med Virol 16 151-165
  • [20] Basu A(1994)Field evaluation of formalin inactivated Kyasanur forest disease virus tissue culture vaccine in 3 districts of Karnataka state Indian J Med Res 99 152-158
12345678910